Exelixis, Inc. (LON:0IJO)
London flag London · Delayed Price · Currency is GBP · Price in USD
42.83
+0.24 (0.56%)
At close: Feb 12, 2026

Exelixis Revenue

In the year 2025, Exelixis had annual revenue of $2.32B USD with 6.98% growth. Exelixis had revenue of $598.66M in the quarter ending December 31, 2025, with 5.63% growth.

Revenue
$2.32B
Revenue Growth
+6.98%
P/S Ratio
4.74
Revenue / Employee
$2.15M
Employees
1,077
Market Cap
8.17B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.32B151.43M6.98%
Dec 31, 20242.17B338.49M18.49%
Dec 31, 20231.83B219.15M13.60%
Dec 31, 20221.61B176.09M12.27%
Dec 31, 20211.43B447.43M45.31%
Dec 31, 2020987.54M19.76M2.04%
Dec 31, 2019967.78M113.95M13.35%
Dec 31, 2018853.83M401.35M88.70%
Dec 31, 2017452.48M261.02M136.34%
Dec 31, 2016191.45M154.28M415.05%
Dec 31, 201537.17M12.06M48.03%
Dec 31, 201425.11M-6.23M-19.87%
Dec 31, 201331.34M-16.11M-33.96%
Dec 31, 201247.45M-242.19M-83.62%
Dec 31, 2011289.64M104.59M56.52%
Dec 31, 2010185.05M33.29M21.93%
Dec 31, 2009151.76M33.90M28.76%
Dec 31, 2008117.86M4.39M3.87%
Dec 31, 2007113.47M14.80M15.00%
Dec 31, 200698.67M22.71M29.90%
Dec 31, 200575.96M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca43.64B
GSK plc32.67B
Haleon11.02B
Smith & Nephew4.33B
Hikma Pharmaceuticals2.35B
Convatec Group1.72B
CVS Group673.20M
Genus672.80M
Revenue Rankings